NPHP1: A Potential Drug Target Or Biomarker for Cancer and Diabetes

Target Name: NPHP1

NCBI ID: G4867

NPHP1

NPHP1: A Potential Drug Target Or Biomarker for Cancer and Diabetes

NPHP1 (Nephrocystin 1) is a protein that is expressed in the kidney, and its levels have been found to be decreased in individuals with various diseases, including diabetes, heart failure, and cancer. NPHP1 has also been shown to play a role in the development of certain types of cancer, and is Therefore, it is a potential drug target or biomarker for these diseases.

One of the main functions of NPHP1 is its role in the regulation of water and electrolyte balance in the body. This protein helps to regulate the amount of water and electrolytes that are lost in the urine, and ensures that the body has an adequate supply of these important substances.

In addition to its role in regulation, NPHP1 has also been shown to play a key role in the development and progression of certain diseases. For example, studies have shown that individuals with certain types of cancer, such as neurobladder cancer and kidney cancer, have lower levels of NPHP1 than those without the disease. Additionally, NPHP1 has been shown to be decreased in the urine samples of individuals with neurobladder cancer and other kidney diseases.

These findings suggest that NPHP1 may be a useful drug target or biomarker for certain types of cancer, as well as for diseases such as diabetes, heart failure, and cancer. Researchers are currently studying the potential uses of NPHP1, and are exploring ways to use it as a treatment or diagnostic tool.

It is important to note that while NPHP1 is a potential drug target or biomarker for certain diseases, more research is needed to fully understand its role and potential uses. Additionally, the safety and effectiveness of using NPHP1 as a treatment or diagnostic tool have not been fully established, and more studies are needed to determine its potential risks and benefits.

Overall, NPHP1 is a protein that has been shown to play a role in the regulation of water and electrolyte balance in the body, and its levels have been found to be decreased in individuals with various diseases. These findings suggest that NPHP1 may be a potential drug target or biomarker for certain types of cancer, as well as for diseases such as diabetes, heart failure, and cancer. Further research is needed to fully understand its role and potential uses.

Protein Name: Nephrocystin 1

Functions: Together with BCAR1 it may play a role in the control of epithelial cell polarity (By similarity). Involved in the organization of apical junctions in kidney cells together with NPHP4 and RPGRIP1L/NPHP8 (By similarity). Does not seem to be strictly required for ciliogenesis (By similarity). Seems to help to recruit PTK2B/PYK2 to cell matrix adhesions, thereby initiating phosphorylation of PTK2B/PYK2 and PTK2B/PYK2-dependent signaling (By similarity). May play a role in the regulation of intraflagellar transport (IFT) during cilia assembly. Required for normal retina development (By similarity). In connecting photoreceptor cilia influences the movement of some IFT proteins such as IFT88 and WDR19. Involved in spermatogenesis (By similarity)

The "NPHP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPHP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets